Patents by Inventor Olivier Busnel

Olivier Busnel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CANCER
    Publication number: 20160237042
    Abstract: Piperazinyl derivatives of formula (I) and their use as a drug, particularly for the treatment of cancer, are disclosed. Also disclosed are pharmaceutical compositions comprising the piperazinyl derivatives, and methods for synthesizing the piperazinyl derivatives.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 18, 2016
    Inventors: Denis CARNIATO, Jean-Francois BRIAND, Mathieu GUTMANN, Olivier BUSNEL, Cécile BOUGERET, Benoit DEPREZ, Karine JAILLARDON
  • Peptide analogues comprising at least one type of aminoacylaza-$g(b)3and the use thereof, in particular for therapy
    Patent number: 9017673
    Abstract: The object of the present invention is analogues of peptides or parent proteins, these peptide analogues, comprising at least one aza-?3 aminoacyl residue, and also their uses in pharmaceutical compositions or for the diagnosis of pathologies wherein the aforesaid peptides or parent proteins are involved.
    Type: Grant
    Filed: June 11, 2004
    Date of Patent: April 28, 2015
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Michèle Floc'h Baudy, Olivier Busnel, Sylviane Muller
  • Compounds which can be used for the treatment of cancers
    Patent number: 8519188
    Abstract: The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: August 27, 2013
    Assignee: Marc-Henry Pitty
    Inventors: Denis Carniato, Karine Jaillardon, Olivier Busnel, Mathieu Gutmann, Jean-Francois Briand, Benoit Deprez, Dominique Thomas, Cécile Bougeret
  • Compounds which can be used for the Treatment of Cancers
    Publication number: 20110104162
    Abstract: The present invention relates to a compound of general formula (I): and also to the pharmaceutically acceptable salts thereof, to the isomers or isomer mixtures thereof in all proportions, in particular to an enantiomer mixture, and especially to a racemic mixture. The present invention also relates to the use of these compounds as a medicament, and in particular for the treatment of cancer, and also to the compositions containing them.
    Type: Application
    Filed: June 15, 2009
    Publication date: May 5, 2011
    Applicant: Cytomics Systems
    Inventors: Denis Carniato, Karine Jaillardon, Olivier Busnel, Mathieu Gutmann, Jean-Francois Briand, Benoit Deprez, Dominique Thomas, Cécile Bougeret
  • Peptide analogues comprising at least one type of aminoacylaza-$g(b)3and the use thereof, in particular for therapy
    Publication number: 20110044974
    Abstract: The object of the present invention is analogues of peptides or parent proteins, these peptide analogues, comprising at least one aza-?3 aminoacyl residue, and also their uses in pharmaceutical compositions or for the diagnosis of pathologies wherein the aforesaid peptides or parent proteins are involved.
    Type: Application
    Filed: June 11, 2004
    Publication date: February 24, 2011
    Inventors: Michele Baudy Floc'h, Olivier Busnel, Sylviane Muller